Nov 16 (Reuters) - Verily:
* ALPHABET’S VERILY ENDING SMART CONTACT LENS PROGRAM TO MEASURE GLUCOSE LEVELS FOR DIABETICS
* VERILY SAYS HAVE DECIDED, TOGETHER WITH ALCON, NOVARTIS’ EYE-CARE DIVISION, TO PUT GLUCOSE-SENSING LENS WORK ON HOLD
* VERILY SAYS CONTINUING TO FOCUS ON SMART ACCOMMODATING CONTACT LENS AND SMART INTRAOCULAR LENS PROJECTS
* VERILY- CLINICAL WORK ON GLUCOSE-SENSING LENS SHOWED INSUFFICIENT CONSISTENCY IN MEASURING CORRELATION BETWEEN TEAR GLUCOSE AND BLOOD GLUCOSE CONCENTRATIONS TO SUPPORT MEDICAL DEVICE REQUIREMENTS
* VERILY - CLINICAL STUDIES ON GLUCOSE-SENSING LENS SHOWED CHALLENGES IN ACHIEVING STEADY STATE CONDITIONS NECESSARY FOR RELIABLE TEAR GLUCOSE READINGS Source text: (bit.ly/2QNN3IG) Further company coverage:
